Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV
- 20 July 2005
- Vol. 23 (46-47) , 5306-5320
- https://doi.org/10.1016/j.vaccine.2005.07.008
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- HIV Dodges One-Two PunchScience, 2004
- Effects of Antibody on Viral Kinetics in Simian/Human Immunodeficiency Virus Infection: Implications for VaccinationJournal of Virology, 2004
- Rapid CD4+ T-Lymphocyte Depletion in Rhesus Monkeys Infected with a Simian–Human Immunodeficiency Virus Expressing the Envelope Glycoproteins of a Primary Dual-Tropic Ethiopian Clade C HIV Type 1 IsolateAIDS Research and Human Retroviruses, 2004
- Age Distribution for T Cell Reactivity to Vaccinia Virus in a Healthy PopulationClinical Infectious Diseases, 2004
- Cellular Immunity Elicited by Human Immunodeficiency Virus Type 1/ Simian Immunodeficiency Virus DNA Vaccination Does Not Augment the Sterile Protection Afforded by Passive Infusion of Neutralizing AntibodiesJournal of Virology, 2003
- Method for Simultaneous Measurement of Antibodies to 23 Pneumococcal Capsular PolysaccharidesClinical and Vaccine Immunology, 2003
- Limited Breadth of a T-Helper Cell Response to a Human Immunodeficiency Virus Envelope ProteinJournal of Virology, 2003
- In vivo adaptation of SHIVSF162: Chimeric virus expressing a NSI, CCR5‐specific envelope proteinJournal of Medical Primatology, 1999
- Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinantsVaccine, 1997
- Does the Key to a Successful HIV Type 1 Vaccine Lie among the Envelope Sequences of Infected Individuals?AIDS Research and Human Retroviruses, 1995